Small-molecule CB002 restores p53 pathway signaling and represses colorectal cancer cell growth.
|
| Abstract |
Much effort is currently focused on the p53 pathway. p53 is a key tumor suppressor, which is mutated or lost in many human cancers. Restoration of the p53 pathway holds the potential to induce selective cell death in tumor cells without harming normal cells that have intact p53 pathways. Most tumor cells express mutated p53 or suppress p53 by overexpression of MDM2. In this study, a compound referred to as CB002 with one closely related compound from the Chembridge library were evaluated for tumor cytotoxicity without affecting normal cells by restoration of the p53 pathway. A decrease of mutant p53 protein expression, restoration of inactivated p53, or some activation of p73 are candidate mechanisms this agent could cause tumor cell apoptosis and growth arrest. We further show that CB002 activates p53 pathway signaling in part via p73 in p53 mutant cancer cell lines. However, it is important to note that we have not established a role for p73 in the anti-tumor effect of CB002 or R1. CB002 causes tumor cell death with synergistic effects with traditional chemotherapeutics CPT-11 and 5-FU.
|
|---|---|
| Authors | Colby Richardson, Shengliang Zhang, Liz J Hernandez Borrero, Wafik S El-Deiry |
| Journal | Cell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 16 Issue 18 Pg. 1719-1725 (Sep 17 2017) ISSN: 1551-4005 [Electronic] United States |
| PMID | 28749206 (Publication Type: Journal Article) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!